This Week in BMC Cancer

Premium

In BMC Cancer this week, researchers in Greece report on the role of thymidylate synthetase, or TYMS, in non-small-cell lung cancer. The team examined the mRNA expression of DNA repair and replication genes BRCA1, ERCC1, RRM1, and TYMS in 276 NSCLC samples and found that expression of all four genes was increased in tumors compared to matched normal lung parenchyma. In particular, the researchers found that aberrant intratumoral TYMS expression predicted shorter progression-free survival.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.